BNP PARIBAS FINANCIAL MARKETS - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,495,558
+17.3%
83,318
+32.7%
0.00%0.0%
Q2 2023$1,275,163
-57.2%
62,785
-61.6%
0.00%
-50.0%
Q1 2023$2,978,519
+223.5%
163,296
+266.7%
0.00%
+300.0%
Q4 2022$920,818
-100.0%
44,527
-67.5%
0.00%
-83.3%
Q3 2022$3,582,795,000
+121.8%
136,957
+114.8%
0.01%
+100.0%
Q2 2022$1,615,501,000
+389.3%
63,753
+509.4%
0.00%
Q1 2022$330,181,000
-52.7%
10,462
-39.4%
0.00%
-100.0%
Q4 2021$698,148,000
+73.1%
17,251
+49.2%
0.00%0.0%
Q3 2021$403,272,000
+158.3%
11,565
+103.4%
0.00%
Q2 2021$156,138,000
-0.9%
5,686
+1.3%
0.00%
Q1 2021$157,585,000
-1.6%
5,612
-9.0%
0.00%
Q4 2020$160,069,000
-14.6%
6,166
-43.6%
0.00%
Q3 2020$187,443,000
+119.4%
10,936
+216.7%
0.00%
Q2 2020$85,427,000
-38.6%
3,453
-65.6%
0.00%
Q1 2020$139,175,000
+74.7%
10,027
+27.1%
0.00%
Q4 2019$79,669,000
+74.0%
7,888
+56.8%
0.00%
Q3 2019$45,782,000
+11.8%
5,031
-2.3%
0.00%
Q2 2019$40,950,000
-49.7%
5,151
-21.0%
0.00%
Q1 2019$81,447,000
+2256.0%
6,521
+1931.5%
0.00%
Q4 2018$3,457,000
+46.7%
321
+89.9%
0.00%
Q3 2018$2,356,000
+13.2%
169
-0.6%
0.00%
Q2 2018$2,081,0001700.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders